206 related articles for article (PubMed ID: 15733528)
1. The suspension of an announced trial on relapse prevention in Crohn's ileitis with a 5-ASA formulation in microgranular form.
Prantera C; Bellinvia S
Dig Liver Dis; 2005 Feb; 37(2):135-6. PubMed ID: 15733528
[No Abstract] [Full Text] [Related]
2. Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial.
Prantera C; Cottone M; Pallone F; Annese V; Franzè A; Cerutti R; Bianchi Porro G
Gastroenterology; 1999 Mar; 116(3):521-6. PubMed ID: 10029609
[TBL] [Abstract][Full Text] [Related]
3. Anastomotic configuration and mucosal 5-aminosalicyclic acid (5-ASA) concentrations in patients with Crohn's disease: a GISC study. Gruppo Italiano per lo Studio del Colon e del Retto.
Frieri G; Pimpo MT; Palumbo G; Tonelli F; Annese V; Sturniolo GC; Andreoli A; Comberlato M; Corrao G; Caprilli R
Am J Gastroenterol; 2000 Jun; 95(6):1486-90. PubMed ID: 10894584
[TBL] [Abstract][Full Text] [Related]
4. Current treatment for prevention of relapse and recurrence in Crohn's disease.
Prantera C; Scribano ML
Ital J Gastroenterol Hepatol; 1999; 31(6):515-8. PubMed ID: 10575572
[TBL] [Abstract][Full Text] [Related]
5. Can postoperative relapse of Crohn's disease be prevented?
Dumois RA; Herrera JL
Am J Gastroenterol; 2001 Jan; 96(1):249. PubMed ID: 11197264
[No Abstract] [Full Text] [Related]
6. Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.
Feagan BG
Eur J Surg; 1998 Dec; 164(12):903-9. PubMed ID: 10029385
[No Abstract] [Full Text] [Related]
7. Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's disease.
Thomson AB; Wright JP; Vatn M; Bailey RJ; Rachmilewitz D; Adler M; Wilson-Lynch KA
Aliment Pharmacol Ther; 1995 Dec; 9(6):673-83. PubMed ID: 8824656
[TBL] [Abstract][Full Text] [Related]
8. Mesalamine derivatives in the treatment of Crohn's disease.
Harrell LE; Hanauer SB
Gastroenterol Clin North Am; 2004 Jun; 33(2):303-17, ix-x. PubMed ID: 15177540
[TBL] [Abstract][Full Text] [Related]
9. [Improved treatment of Crohn's disease].
Nau JY
Rev Med Suisse; 2005 May; 1(18):1241. PubMed ID: 15977716
[No Abstract] [Full Text] [Related]
10. Presentation of Crohn's disease as metastatic cutaneous non-caseating granulomatous lesions.
Delgado J; Delgado B; Sztarkier I; Cagnano E; Sperber AD; Fich A
Isr Med Assoc J; 2003 Dec; 5(12):897-8. PubMed ID: 14689766
[No Abstract] [Full Text] [Related]
11. [Angioedema in Crohn's disease possibly due to mesalazine].
Nguyen-Khac E; Le Baron F; Thevenot T; Tiry-Lescut C; Tiry F
Gastroenterol Clin Biol; 2002 May; 26(5):535-6. PubMed ID: 12122371
[No Abstract] [Full Text] [Related]
12. Prevention of postoperative recurrence in Crohn's disease.
Terdiman JP
Clin Gastroenterol Hepatol; 2008 Jun; 6(6):616-20. PubMed ID: 17967564
[No Abstract] [Full Text] [Related]
13. [Mesalazine is effective in Crohn disease 2].
Quartarolo JP; Laegemidler F; Eskerod O
Ugeskr Laeger; 2005 Mar; 167(11):1308-9; author reply 1309. PubMed ID: 15830510
[No Abstract] [Full Text] [Related]
14. [Mesalazine is effective in Crohn disease 1].
Fallingborg J; Langholz E; Christensen LA; Munkholm P; Dahlerup JF
Ugeskr Laeger; 2005 Mar; 167(11):1307-8; author reply 1309. PubMed ID: 15830509
[No Abstract] [Full Text] [Related]
15. Mesalamine and relapse prevention in Crohn's disease.
Cottone M; Cammà C
Gastroenterology; 2000 Aug; 119(2):597. PubMed ID: 10960274
[No Abstract] [Full Text] [Related]
16. A comparison of budesonide and mesalamine for active Crohn's disease.
Lowry PW; Sandborn WJ
Gastroenterology; 1999 May; 116(5):1263. PubMed ID: 10220523
[No Abstract] [Full Text] [Related]
17. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
[TBL] [Abstract][Full Text] [Related]
18. [Mesalazine is without clinical effect in patients with Crohn disease].
Munck LK
Ugeskr Laeger; 2005 Jan; 167(3):302-3. PubMed ID: 15704804
[No Abstract] [Full Text] [Related]
19. [Ulcerous colitis and Crohn's disease in members of one family: case description and review of literature].
Neĭman KP; Rumiantsev VG
Eksp Klin Gastroenterol; 2006; (3):56-60. PubMed ID: 17203844
[No Abstract] [Full Text] [Related]
20. [Mesalamine in the treatment of Crohn disease?].
Nielsen OH; Thomsen OO
Ugeskr Laeger; 2005 Apr; 167(15):1656-7. PubMed ID: 15892345
[No Abstract] [Full Text] [Related]
[Next] [New Search]